Integrin alpha(v)beta(3) expression in colon carcinoma correlates with survival

Area of Science:

• Oncology
• Molecular Biology
• Vascular Biology

Background:

• Integrin alpha(v)beta(3) is a cell surface receptor implicated in angiogenesis.
• Newly formed blood vessels in diseased and neoplastic tissues express integrin alpha(v)beta(3).
• This integrin can serve as a potential marker for angiogenesis.

Purpose of the Study:

• To investigate the expression of integrin alpha(v)beta(3) in colon carcinomas.
• To evaluate the correlation between integrin alpha(v)beta(3) expression and patient prognosis.
• To determine if integrin alpha(v)beta(3) can be used as a prognostic indicator for colon cancer.

Main Methods:

• Utilized the anti-alpha(v)beta(3)-specific monoclonal antibody LM609.
• Examined integrin alpha(v)beta(3) expression on the vasculature of 40 colon carcinoma samples.
• Correlated expression levels with relapse-free interval, overall survival, and presence of liver metastases.

Main Results:

• Patients with high vascular integrin alpha(v)beta(3) expression had significantly reduced relapse-free intervals and overall survival.
• A significant correlation was observed between high integrin alpha(v)beta(3) expression and the presence of liver metastases.
• Low integrin alpha(v)beta(3) expression was associated with better patient outcomes.

Conclusions:

• Vascular expression of integrin alpha(v)beta(3) is a significant prognostic indicator in colon carcinoma.
• High expression suggests aggressive tumor behavior and increased metastatic potential.
• Integrin alpha(v)beta(3) warrants further investigation as a therapeutic target and prognostic biomarker in colon cancer.